Authors:
Li, WB
Friedland, W
Pomplun, E
Jacob, P
Paretzke, HG
Lassmann, M
Reiners, C
Citation: Wb. Li et al., Track structures and dose distributions from decays of I-131 and I-125 in and around water spheres simulating micrometastases of differentiated thyroid cancer, RADIAT RES, 156(4), 2001, pp. 419-429
Authors:
Luster, M
Reinhardt, W
Korber, C
Lassmann, M
Haenscheid, H
Michalowski, U
Rendl, J
Eising, E
Mann, K
Reiners, C
Citation: M. Luster et al., The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production, J ENDOC INV, 23(7), 2000, pp. 473-475
Authors:
Luster, M
Lassmann, M
Haenscheid, H
Michalowski, U
Incerti, C
Reiners, C
Citation: M. Luster et al., Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma, J CLIN END, 85(10), 2000, pp. 3640-3645
Citation: C. Reiners et M. Lassmann, Radioiodine (I-131) treatment of hyperthyroidism: radiation protection andquality assurance, EUR J NUCL, 26(7), 1999, pp. 683-685
Authors:
Reiners, C
Hanscheid, H
Lassmann, M
Tiemann, M
Kreissl, M
Rendl, J
Bier, D
Citation: C. Reiners et al., X-ray fluorescence analysis (XFA) of thyroidal iodine content (TIC) with an improved measuring system, EXP CL E D, 106, 1998, pp. S31-S33